Primobolan is considered one of the safest anabolic steroids on the market and it carries an excellent safety rating to back this claim. In fact, this steroid has been used successfully to treat underweight children and premature infants without damage. It is also prescribed for osteoporosis and sarcopenia. However, the primary purpose of Primobolan 10 is treating muscle wasting diseases and prolonged exposure to corticoid hormones. It has also proven to be extremely effective in treating malnutrition.
Known as Methenolone Enanthate (or Primobolan Depot), is one of the most sought after, and hard to find steroid compounds on the market. Often underrated, Primobolan is a potent compound for both lean bulking and cutting. Being a dihydrotestosterone (DHT) derived anabolic steroid, it doesn’t have estrogenic side effects such as water retention or gynecomastia. It is usually considered a mild steroid and can be run during a lean bulk or a cutting cycle. The lack of adverse side effects makes it one of the most popular compounds for both men and women. If you desire a hard, lean, next level physique, try Primobolan.
Benefits:
- Generally considered the safest injectable steroid
- Ideal for lean bulking & cutting
- Quality lean muscle tissue gains
- Makes muscles appear dry and hard
- Increased endurance
- Helps preserve lean muscle during a calorie deficit
- Enhanced immune system
- Increased energy and mental focus
- Does not aromatize
Terminal Half-life:
- 5 days
Possible Dosage & Cycle Length:
- Men @ 300-900 mg/week
- Women @ 25-100 mg/week
- 8-16 weeks
Primobolan Acetate is an oral steroid that is commonly used by females. This version of Primobolan is preferred by females as females tend to require much lower doses than Primobolan compared to men. Although some men do choose to use Primobolan tablets, most prefer to go with the Injectable version of Primobolan.
Primobolan Acetate is also not liver toxic at all, compared to many other oral steroids which makes it a very safe option.
Reviews
There are no reviews yet.